Women's Health

News on women's health diagnostics, including prenatal testing, STD testing, and cancer testing

The Class III Medical Device System License enables an early-risk assessment of the most common fetal genetic abnormalities in the first trimester of pregnancy.

The test runs on the BD Viper LT system and detects 14 high-risk types of human papilloma virus.

Private equity firm Quadria Capital led the investment round and was joined by HealthQuad Fund and Heritas Venture Fund.

The Salt Lake City-based firm expects to launch a test in the infertility space this year and is also involved in endometriosis therapeutics development.

The genetic testing firm can now offer its Prelude noninvasive prenatal test to residents in New York State.

Counsyl Raises $80M